Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Kidney Injury molecule-1 (KIM-1)
100%
Cardiovascular Assessment
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Canagliflozin
100%
Assessment Study
100%
Plasma Biomarkers
100%
Tumor Necrosis Factor Receptor 1 (TNFR1)
100%
Tumor Necrosis Factor Receptor 2 (TNFR2)
100%
Biomarkers Tumor
100%
Kidney Outcomes
28%
Placebo
21%
Type 2 Diabetes Mellitus (T2DM)
21%
High Risk
14%
Low Risk
14%
Early Change
14%
Treatment Group
7%
Kidney Disease Progression
7%
Plasma Concentration
7%
Multivariable
7%
Cox Regression
7%
Patient Characteristics
7%
Immunoassay
7%
Multiplex Assay
7%
Response Marker
7%
Cardiovascular Outcomes
7%
Pharmacodynamic Markers
7%
Heart Failure Outcomes
7%
Cardiovascular Failure
7%
Mixed Model Repeated Measures
7%
Kidney Failure
7%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Tumor Necrosis Factor Receptor 1
100%
Tumor Necrosis Factor Receptor 2
100%
Kidney Injury Molecule 1
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Canagliflozin
100%
Placebo
21%
Maturity Onset Diabetes of the Young
21%
Kidney Failure
7%
Disease Exacerbation
7%
Kidney Disease
7%
Pharmacodynamics
7%
Immunoassay
7%
Congestive Heart Failure
7%
Cotransporter
7%
Treatment Group
7%
Immunology and Microbiology
Blood Plasma
100%
Tumor Necrosis Factor Receptor 1
100%
Tumor Necrosis Factor Receptor 2
100%
Cardiovascular System
100%
Cotransporter
12%
Immunoassay
12%
Pharmacodynamics
12%